Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis.

Blanca T Pacheco-SotoRebeca Garazi Elguezabal-RodeloLeonardo M PorchiaEnrique Torres-RasgadoRicardo Pérez-FuentesMartha Elba Gonzalez-Mejia

Published in: Journal of drug assessment (2021)

Denosumab significantly improved glycemic parameters. This outcome was more prominent for subjects with compromised glucose tolerance, positing that Denosumab can be used as a treatment to improve glucose metabolism for persons with pre-diabetes and diabetes.

Keyphrases

bone mineral density
type diabetes
giant cell
glycemic control
cardiovascular disease
postmenopausal women
blood glucose
body composition
insulin resistance
blood pressure
replacement therapy